Testosterone Gel
Perrigo Confirms First to File Patent Challenge for Generic Version of Testosterone Gel 1.62%
Perrigo Co. (Nasdaq: PRGO) announced that it has filed with the U.S. Food and Drug Administration an Abbreviated New Drug Application for testosterone gel 1.62 percent and that it has notified AbbVie Inc., the owner of the Reference Listed Drug of its filing.
Perrigo Confirms FDA Approval For Testosterone Gel 1%
Perrigo Company (Nasdaq: PRGO) announced that it has received U.S. Food and Drug Administration approval for its New Drug Application for testosterone gel 1%. Perrigo’s NDA included a bioequivalence study that compared its product to AbbVie’s AndroGel 1%.
Perrigo Confirms Filing For Testosterone Gel And Patent Infringement Lawsuit
Allegan’s Perrigo confirms a regulatory finding for generic testosterone gel and a lawsuit by the company that makes the patented version.



Detroit Tigers @ Cleveland...
Detroit Tigers @ Cleveland...
Student Construction Science...
Detroit Red Wings Vs. Chicago...
Ticket Chicks At The Detroit...
Detroit Tigers @ Texas...
Detroit Tigers @ Texas...
Detroit Red Wings @ Chicago...
Detroit Tigers @ Texas...
Detroit Tigers @ Texas...
Detroit Red Wings @ Chicago...
Detroit Tigers Vs. Houston...
Detroit Tigers Vs. Houston...
Detroit Tigers Vs. Houston...
Detroit's Robocop Statue...
Detroit Red Wings @ Anaheim...